We cut through deal noise to give founders and buyers the pragmatic data they need. Our approach pairs transaction expertise with digital tools drawn from an international network.
Access to reliable market benchmarks matters. The KPMG Multiples database covers over 17,500 companies across 74 industries, letting us focus on the median EBITDA multiples that shape current market pricing.
That clarity helps you align a realistic thesis with real-world performance. Whether your company is in health, food, or technology, we supply curated information to bridge expectations between buyers and sellers.
Make better decisions faster. We guide management of capital structure, price-setting, and growth planning so exits are planned, not hoped for. Learn more about the drivers behind these figures in our deep dive on understanding your multiple.
Key Takeaways
- We use broad market data to ground pricing conversations.
- The KPMG database offers depth: 17,500+ companies across 74 sectors.
- Median EBITDA figures give a realistic starting point for deals.
- Our tools help founders and buyers close the expectation gap.
- Strong capital management and repeatable revenue raise value.
Thinking about selling your business?
A 15-minute confidential call gives you a real valuation range and the buyers most likely to compete for your business. No cost, no obligation.
Understanding the Fundamentals of Business Valuation
For 2026 valuation multiples by industry across 30+ industries, see our reference table.
We start every appraisal by turning earnings into an actionable baseline. The basic method links a chosen earnings figure to a simple multiple to estimate value. This gives a repeatable, market-aligned result.
What we measure: reliable cash flow proxies, usually EBITDA, and sometimes top-line revenue for early-stage firms. We then apply sector-specific and median benchmarks to set realistic expectations.
Investors want predictable flow. For founder-led companies, we adapt tools to reflect product mixes in health, food, and technology. Good management of financials ensures the final figure tracks equity and enterprise value.
| Metric | Health (median) | Food (median) | Technology (median) |
|---|---|---|---|
| EBITDA (multiple) | 8.0x | 7.0x | 12.0x |
| Revenue (multiple) | 2.0x | 1.8x | 6.5x |
| Primary focus | Stable cash | Margin mix | Growth trajectory |
- Process over guesswork. We project future potential, not just list assets.
- Benchmarks reduce subjectivity. Use median references to avoid pricing traps.
Why Valuation Multiples by Industry Matter for M&A
Objective peer metrics stop buyers from anchoring on vague references. We lean on curated transaction data to ground strategy. That gives sellers a clear negotiating stance and buyers a realistic target.
Strategic Decision Making
We use DealStats records from 1990 to July 2024 to inform decisions. Those private transaction entries exclude extreme deals over 30x ebitda, preserving median integrity.
Why it matters: median ebitda and revenue figures let you benchmark sales, growth, and management performance against peers in health, food, and technology.
Avoiding Undervaluation
Don’t leave money on the table. Armed with sector medians and curated data, you can justify your price and counter generic offers that compress value.
| Measure | Health (median) | Food (median) | Technology (median) |
|---|---|---|---|
| EBITDA (median) | 8.0x | 7.0x | 12.0x |
| Revenue multiple (median) | 2.0x | 1.8x | 6.5x |
| What it shows | Stable cash and management | Margin mix and sales | Growth and product traction |
For practical help, review our M&A advisory services to align your thesis with real market signals.
Trading Multiples Versus Transaction Multiples
Trading and transaction measures capture value from different angles; one looks forward, the other looks backward.
Transaction measures come from completed private sales. They are historical and show what buyers paid after deals closed. Use them to validate real-world price outcomes.
Trading measures use listed peer groups. They combine past results and market expectations to project future value. That makes them forward-looking and useful for growth-focused companies.
Why this matters: choosing the wrong set of benchmarks can skew your company price. We compare peers in health, food, and technology to recommend the best route for your sale or raise.
- Transaction data = closed sales; helps confirm median exit prices.
- Trading data = listed peers; gives a forward view of revenue and ebitda trends.
- We match the approach to your company, products, and capital plan.
Our team makes sure the information you use is relevant and current. We guide founders through the practical trade-offs so your exit thesis aligns with real market signals.
Distinguishing Between Entity and Equity Multiples
Debt and cash move the needle on what a company actually sells for. We separate enterprise-focused measures from equity-level ones so you use the right yardstick.
Entity multiples such as an ebitda multiple capture enterprise value. They include both debt and equity and show total claims on the business.
The Impact of Capital Structure
Equity multiples, think P/E, reflect only shareholder value and ignore net debt. That can mislead when leverage is high or cash balances are material.
- Entity measures give a fuller view of market value.
- Equity measures focus on value equity for owners.
- High debt will compress enterprise price if not adjusted.
- We adjust numbers for cash, interest-bearing liabilities, and one-offs.
| Measure | Entity view | Equity view |
|---|---|---|
| Common metric | EV / EBITDA | P / E |
| Includes debt? | Yes | No |
| Use when | Comparing companies with different leverage | Assessing shareholder price |
“Adjust for capital structure first; then compare medians. Apples to apples matters.”
The Role of Revenue Multiples in Early Stage Startups
When earnings are negative, revenue offers a practical lens for pricing. We use top-line figures to create a repeatable, transparent starting point for conversations with buyers and founders.
Calculating the Revenue Multiple
Formula: selling price ÷ annual revenue. This simple ratio gives a clear signal when cash flow and profit are unstable.
We prefer enterprise value to sales when possible. It adjusts for debt and gives a truer picture than a plain price-to-sales number.
Benefits for Startups
Useful for early-stage companies: revenue metrics apply even if earnings are negative. They help compare growth across health, food, and technology.
Revenue-based measures make it easier to anchor discussions when management lacks steady ebitda figures. For a deeper dive on this topic, see our guide on how deferred consideration works in MA transactions.
Limitations of Revenue-Based Metrics
Be aware: revenue does not show profit margins or cash flow. A high revenue multiple can mask weak margins or heavy debt. Related: our walkthrough on trailing twelve months the metric that matters most for MA.
We combine revenue analysis with sector median ebitda and curated data so the final price reflects both sales and underlying value.
- Revenue multiple = selling price / annual revenue (core calculation).
- Enterprise value-to-sales offers more complete insight than price-to-sales.
- Use revenue metrics alongside ebitda multiples and median benchmarks for balanced assessment.
For a practical walk-through of startup math and market signals, see our startup valuation guide.
Analyzing EBITDA Multiples Across Diverse Sectors
A $500k ebitda can mean very different outcomes depending on which sector you sit in. Owners often confuse the two terms — our guide on valuation vs evaluation walks through when each applies.
Using a median ebitda of 5.4x for manufacturing, that earnings level implies a roughly $2.7M enterprise value. The math is simple and repeatable. It gives sellers and buyers a quick, market-aligned starting point.
What changes the number: company size, margin profile, and management depth. Larger firms in health, food, and technology often command higher medians because they scale operations and reduce per-unit costs.
EBITDA multiples vary inside sectors. That variance affects price more than headline averages. We pull curated market data so you can see where your company sits on that range.
- Median ebitda gives a directional price for a sale or raise.
- Scale and governance push medians higher for larger companies.
- Use revenue and ebitda figures together for a fuller view.
“Use medians as a compass, not a guarantee.”
Key Factors Influencing Valuation Multiples
Depth of leadership and a repeatable operating model change what buyers will pay. If any valuation terms are unfamiliar, our business valuation terms glossary covers 40+ standard definitions.
Investors buy systems as much as sales. Think Ray Kroc: he paid for a scalable playbook, not just burgers. For a deeper dive on this topic, see our guide on mastering basket and cap in MA indemnification.
Primary drivers include management strength, organizational efficiency, access to capital, and earnings stability.
Companies in health, food, and technology that show steady ebitda and clear growth paths earn higher median pricing. Stable revenue and reliable margins matter.
- Proprietary products and customer stickiness raise perceived value.
- Strong governance and repeatable processes compress risk for buyers.
- Ready access to capital lets firms scale faster and command a premium.
We use professional tools to map your company against median benchmarks. That helps you frame a clear thesis for buyers and argues for a higher exit price.
business valuation multiples is a useful reference when you want to compare your metrics to market medians.
Common Pitfalls When Applying Industry Benchmarks
Benchmarks help, but unadjusted figures mislead more often than they guide. We see founders lean on medians and expect a clean swap from data to deal. That rarely works.
Accounting for non-recurring items
One-off costs or unusual gains distort earnings and revenue. Ignore them and the calculated multiple will misstate your business value.
We normalize statements. We remove one-time equipment sales, lease termination gains, or exceptional estate charges. That gives buyers a cleaner view of recurring performance.
Practical checks we recommend
- Recast reported earnings to exclude one-offs.
- Compare adjusted revenue to the sector median, not headline averages.
- Flag temporary boosts in technology or food services that inflate short-term numbers.
“Use medians as a compass, then refine with company-level facts.”
We help normalize your books and explain why benchmarks are a starting point, not a final price. Getting this right prevents undervaluing your firm or setting unrealistic expectations that derail a sale.
Leveraging Professional Tools for Accurate Valuations
Accurate tools turn raw financials into defendable market positions. We recommend professional platforms that automate calculations, reduce manual error, and keep reports consistent.
Practical use: Eqvista offers 409a reports and handles revenue multiple calculations. That helps set a clear market value and supports price conversations with buyers and investors.
Automated services standardize inputs. They produce repeatable outputs that track median ebitda and revenue figures. That consistency matters in health, food, and technology sectors.
| Tool | Core output | Benefit |
|---|---|---|
| Eqvista | 409a, revenue multiples | Defendable market value; fewer manual mistakes |
| Automated software | Median ebitda reports | Consistent pricing signals for M&A |
| Advisory support | Integration guidance | Aligns pricing and process with buyers |
We pair these tools with expert review. That ensures your price reflects real data, not guesswork. For deeper sector medians and benchmarking, see our guide on EBITDA benchmarks.
“Use automated tools to standardize reports, then overlay expert judgment.” Related: our walkthrough on it services valuation multiples.
Conclusion
Good data turns a vague price hope into a defendable offer. We explored how sector benchmarks and valuation multiples shape clear deal thinking. Use medians as a guide, not a guarantee.
Understand EBITDA multiple and revenue math. Then pair that analysis with expert services to remove guesswork. That combination raises your odds of achieving higher value.
Focus on growth drivers, normalize earnings, and avoid one-off traps. If you want hands-on help, see our sell-side advisory for practical steps to maximize exit outcomes.
We remain committed to giving founders and buyers the information and tools they need to close smarter in health, food, and technology industries.
Curious what your business is actually worth?
A 15-minute confidential call gives you a real valuation range and tells you which buyers would compete for your business. No cost, no obligation, no pressure to sell.
About the Author
Christoph Totter is the founder of CT Acquisitions, a buy-side partner headquartered in Sheridan, Wyoming. We work directly with 100+ buyers, search funders, family offices, lower middle-market PE, and strategic consolidators, including direct mandates with the largest consolidators that other intermediaries cannot access. The buyers pay us when a deal closes, not the seller. No retainer, no exclusivity, no contract until close. Connect on LinkedIn · Get in touch
FAQ
What does "Unlock Industry-Specific Valuation Multiples for M&A Success" mean for buyers?
It means we provide curated benchmarks, relevant enterprise value and equity metrics, tailored to sectors like healthcare, technology, food services, and real estate. That lets you price deals faster, align to a thesis, and move from screening to offer with confidence.
How do we explain the fundamentals of business valuation to an investment committee?
Keep it simple. Focus on cash flow drivers, normalized earnings, and comparable company data. Show enterprise value relative to revenue and EBITDA, highlight growth assumptions, and surface key risks such as cyclicality or customer concentration.
Why do sector-specific valuation metrics matter when we evaluate a target?
Benchmarks reflect capital intensity, margin profiles, and growth expectations unique to each sector. Using the right comparables prevents mispricing, so you avoid overpaying for low-growth assets or underbidding on high-margin businesses.
How do trading multiples differ from transaction multiples and which should we use?
Trading multiples derive from publicly listed peers and show market sentiment. Transaction multiples come from actual M&A deals and reflect control premiums and negotiated terms. Use both: trading for market context, transaction for deal-level realism.
What’s the difference between entity and equity multiples?
Entity (enterprise value) multiples capture the whole business value, debt and equity, useful for operational comparisons. Equity multiples reflect only shareholder value after debt. Capital structure shifts which metric is relevant.
How does capital structure impact the multiple we apply?
Higher leverage lowers equity value given the same enterprise value and increases risk. We adjust for debt, preferred stock, and cash to compare apples-to-apples across targets and to estimate post-close financing needs.
When should we rely on revenue multiples for early-stage startups?
Revenue multiples fit pre-profit companies with strong growth or defensible differentiation. They’re a shorthand for market traction. But use them alongside unit economics, churn, and path-to-profit, never alone.
How do you calculate a revenue multiple in practice?
Divide enterprise value by trailing or forward revenue (choose forward for growth companies). Normalize revenue for one-offs and seasonality, and be explicit whether you use ARR, TTM, or projected sales.
What are the benefits of revenue-based metrics for founders and buyers?
They simplify comparisons across early-stage firms, reward growth, and speed screening. Buyers use them to size upside; founders use them to benchmark pricing against similar rounds or M&A exits.
What limitations should we expect with revenue multiples?
They ignore margins, capital needs, and cost structure. Two companies with identical revenue multiples can have wildly different cash flows. Always validate with EBITDA or free cash flow analysis when available.
How should we interpret EBITDA multiples across sectors like software, healthcare, and manufacturing?
EBITDA multiples reflect margin stability, recurring revenue, and capital intensity. Software and healthcare services typically command higher multiples than manufacturing. Adjust for growth, margin quality, and competitive moat.
What key factors influence the valuation multiple a buyer will accept?
Growth rate, margin sustainability, size, customer concentration, regulatory exposure, and capex needs. Also consider market sentiment, interest rates, and comparable transaction activity.
What are common pitfalls when applying industry benchmarks to a deal?
Blindly applying a median multiple without normalizing for non-recurring items, seasonal revenue, or one-off synergies. Also, ignoring earnouts, working capital adjustments, and post-close integration costs skews price expectations.
How do we account for non-recurring items when using multiples?
Strip one-time gains or expenses from earnings or cash flow and disclose adjustments. Provide pro forma figures, adjusted EBITDA or normalized revenue, so comparables reflect ongoing operations.
Which professional tools help produce accurate deal valuations?
Use a mix: capital markets databases for public comps, M&A transaction databases for deal comps, LBO and DCF models, and diligence tools for financial, tax, and legal review. Combine software with expert judgment.
How do we ensure our multiple selection aligns with our investment thesis?
Start from sector benchmarks, then layer in thesis-specific drivers: buy-and-build potential, margin expansion levers, and customer stickiness. Stress-test scenarios and set clear return hurdles tied to the multiple you’ll pay.